Additional research is still needed around COVID-19, and nearly one in seven (13%) Americans say they’d be open to enrolling in a clinical trial to help develop new COVID-19 therapies. However, many are still expecting more from big pharma when it comes to trial transparency, especially surrounding COVID-19 vaccine/treatment development.